154 related articles for article (PubMed ID: 23170850)
1. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
[TBL] [Abstract][Full Text] [Related]
2. Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer.
Liang J; Yang B; Cao Q; Wu X
Gynecol Obstet Invest; 2016; 81(6):529-536. PubMed ID: 27160772
[TBL] [Abstract][Full Text] [Related]
3. N-myc downstream-regulated gene 1 can promote vasculogenic mimicry and angiogenesis in urothelial carcinoma.
Louis EK; Abdelkawi IF; Refaiy A; Ahmed AM
Virchows Arch; 2024 May; 484(5):827-836. PubMed ID: 38561462
[TBL] [Abstract][Full Text] [Related]
4. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation.
Zhao B; Wu M; Hu Z; Ma Y; Qi W; Zhang Y; Li Y; Yu M; Wang H; Mo W
Signal Transduct Target Ther; 2020 Jul; 5(1):117. PubMed ID: 32647187
[TBL] [Abstract][Full Text] [Related]
5. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer.
Yao L; Dong H; Luo Y; Du J; Hu W
PLoS One; 2014; 9(4):e96206. PubMed ID: 24788022
[TBL] [Abstract][Full Text] [Related]
6. Expression of LGR5 in oral squamous cell carcinoma and its correlation to vasculogenic mimicry.
Wu Z; Song W; Cheng Z; Yang D; Yu L
Int J Clin Exp Pathol; 2017; 10(11):11267-11275. PubMed ID: 31966480
[TBL] [Abstract][Full Text] [Related]
7. The correlation of KAI1, Slug and vasculogenic mimicry in the prediction of metastasis and prognosis in colorectal carcinoma.
Wang M; Wu Q; Jiang Y; Liu Y; Ou Y
Int J Clin Exp Pathol; 2018; 11(10):5034-5043. PubMed ID: 31949580
[TBL] [Abstract][Full Text] [Related]
8. Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry.
Pearsall SM; Williamson SC; Humphrey S; Hughes E; Morgan D; García Marqués FJ; Awanis G; Carroll R; Burks L; Shue YT; Bermudez A; Frese KK; Galvin M; Carter M; Priest L; Kerr A; Zhou C; Oliver TG; Humphries JD; Humphries MJ; Blackhall F; Cannell IG; Pitteri SJ; Hannon GJ; Sage J; Dive C; Simpson KL
J Thorac Oncol; 2023 Oct; 18(10):1362-1385. PubMed ID: 37455012
[TBL] [Abstract][Full Text] [Related]
9. CD133 Expression in the Nucleus Is Associated with Endometrial Carcinoma Staging and Tumor Angioinvasion.
Pietrus M; Pitynski K; Waligora M; Milian-Ciesielska K; Bialon M; Ludwin A; Skrzypek K
J Clin Med; 2021 May; 10(10):. PubMed ID: 34063525
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of angiogenesis in tumour.
Zhang R; Yao Y; Gao H; Hu X
Front Oncol; 2024; 14():1359069. PubMed ID: 38590656
[TBL] [Abstract][Full Text] [Related]
11. EGR1 Regulation of Vasculogenic Mimicry in the MDA-MB-231 Triple-Negative Breast Cancer Cell Line through the Upregulation of KLF4 Expression.
Jung E; Lee YH; Ou S; Kim TY; Shin SY
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762678
[TBL] [Abstract][Full Text] [Related]
12. Live-cell imaging-based dynamic vascular formation assay for antivascular drug evaluation and screening.
Li Z; Zhang H; Sun Y; Feng Z; Cui B; Han J; Li Y; Liu H; Sun T
iScience; 2023 May; 26(5):106721. PubMed ID: 37216092
[TBL] [Abstract][Full Text] [Related]
13. SNORD17-mediated KAT6B mRNA 2'-O-methylation regulates vasculogenic mimicry in glioblastoma cells.
Cui J; Liu X; Dong W; Liu Y; Ruan X; Zhang M; Wang P; Liu L; Xue Y
Cell Biol Toxicol; 2023 Dec; 39(6):2841-2860. PubMed ID: 37058271
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.
Andreucci E; Peppicelli S; Ruzzolini J; Bianchini F; Calorini L
Cancer Metastasis Rev; 2022 Dec; 41(4):935-951. PubMed ID: 36224457
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Pharmaceutical Inhibition of Vasculogenic Mimicry In Vitro.
Manarang JC; McDermott A
Methods Mol Biol; 2022; 2514():129-139. PubMed ID: 35771425
[TBL] [Abstract][Full Text] [Related]
16. Prognosis assessment of CD44
Gu J; Chen D; Li Z; Yang Y; Ma Z; Huang G
Arch Gynecol Obstet; 2022 Oct; 306(4):1147-1160. PubMed ID: 35435483
[TBL] [Abstract][Full Text] [Related]
17. Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer.
Nicoś M; Krawczyk P
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406585
[TBL] [Abstract][Full Text] [Related]
18. Marine Bromophenol Bis(2,3,6-Tribromo-4,5-Dihydroxybenzyl)ether Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells and Reduces Vasculogenic Mimicry in Human Lung Cancer A549 Cells.
Dong S; Chen Z; Wang L; Liu Y; Stagos D; Lin X; Liu M
Mar Drugs; 2021 Nov; 19(11):. PubMed ID: 34822512
[TBL] [Abstract][Full Text] [Related]
19. The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation.
Xu K; Han H; Luo Y; Ye H; Lin H; Ni L
Front Oncol; 2021; 11():663671. PubMed ID: 34221978
[TBL] [Abstract][Full Text] [Related]
20. Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer.
Pourmohammad P; Maroufi NF; Rashidi M; Vahedian V; Pouremamali F; Faridvand Y; Ghaffari-Novin M; Isazadeh A; Hajazimian S; Nejabati HR; Nouri M
Biochem Genet; 2022 Feb; 60(1):1-23. PubMed ID: 34181134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
